Advertisement

NEOS

Neos Therapeutics, Inc.

Set alert

Price alert · NEOS

All alert types

No live quote for NEOS yet.

Open
1.16
Prev close
1.18
Mkt cap
57.22M
Vol
15.01M
Avg vol
7.10M
P/E
0.00
Div yield
0.00%
More statistics
Low
1.06
High
1.18
Forward P/E
-19.17
Beta
0.00
Dividend
0.00
Ex-div date
50-d avg
0.9922
200-d avg
0.733477
1y target
1.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for NEOS has not been loaded yet. Try again in a moment.

Key statistics

Market cap
57.22M
Trailing P/E
0.00
Forward P/E
-19.17
Price / sales
0.00
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
0
Total cash
0
Total debt
0
Return on equity
0.00%
50-day average
0.9922
200-day average
0.733477

Analyst view

Consensus: buy

Buy
Price target (mean) 1.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NEOS Revenue — quarterly 12.54M
2016-Q4 20162017-Q1 20172017-Q2 20172017-Q3 20172017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 2020
NEOS Net income — quarterly -4.91M
2016-Q4 20162017-Q1 20172017-Q2 20172017-Q3 20172017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 2020
NEOS EPS — quarterly -0.10
2016-Q4 20162017-Q1 20172017-Q2 20172017-Q3 20172017-Q4 20172018-Q1 20182018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 2020

Upgrades / downgrades

NEOS analyst upgrades and downgrades
DateFirmActionFromTo
Aug 11, 2019BMO Capitalmain—Market Perform
Nov 11, 2018JMP SecuritiesmainMarket OutperformMarket Outperform
Aug 8, 2018Wells FargomainOutperformOutperform
Jan 30, 2018BMO CapitaldownOutperformMarket Perform
Jul 31, 2017Cantor Fitzgeraldinit—Overweight
Apr 4, 2017Cowen & Co.init—Outperform

News

Your note

Sign in to keep a note on NEOS — it syncs with the Stock Master app.

Insider holders

NEOS insider holders
InsiderRelationLatest transactionDateShares held
EISENSTADT RICHARD IChief Financial OfficerStock Award(Grant)Mar 1, 20200
FONG BRYANT E.DirectorStock Award(Grant)Jun 9, 202024,953
HECHT BETH PDirectorStock Award(Grant)Jun 9, 202023,453
HELLER ALAN LDirectorStock Award(Grant)Jun 9, 2020446,819
LIMONGELLI JOHN MGeneral CounselStock Award(Grant)Mar 1, 2020100,000
MCLAUGHLIN GERALD WChief Executive OfficerStock Award(Grant)Mar 1, 2020314,500

Institution ownership

NEOS institution ownership
Holder% heldSharesValueReported
Stonepine Capital Management, LLC9.97%4,962,6573.10MDec 30, 2020
Vanguard Group, Inc. (The)3.41%1,697,3301.06MDec 30, 2020
Renaissance Technologies, LLC2.16%1,076,683672.60KDec 30, 2020
Blackrock Inc.0.81%401,088250.56KDec 30, 2020
Geode Capital Management, LLC0.68%340,768212.88KDec 30, 2020
Goldman Sachs Group, Inc.0.68%337,188210.64KDec 30, 2020

Fund ownership

NEOS fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.14%1,064,676665.10KDec 30, 2020
Vanguard Extended Market Index Fund1.18%585,390365.69KDec 30, 2020
Fidelity Extended Market Index Fund0.38%188,234146.82KJan 30, 2021
Bridgeway Funds Inc-Ultra Small Company Market Fund0.37%185,000115.57KDec 30, 2020
Fidelity Total Market Index Fund0.12%61,75248.17KJan 30, 2021
iShares Core S&P Total U.S. Stock Market ETF0.12%59,60946.49KJan 30, 2021
Advertisement